Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000475157 | SCV000543587 | uncertain significance | Hereditary nonpolyposis colorectal neoplasms | 2019-09-24 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine with glycine at codon 497 of the MLH1 protein (p.Arg497Gly). The arginine residue is moderately conserved and there is a moderate physicochemical difference between arginine and glycine. This variant is present in population databases (rs200830026, ExAC 0.01%). This variant has been reported in an individual affected with ovarian cancer (PMID: 23047549). ClinVar contains an entry for this variant (Variation ID: 405404). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Color | RCV000774706 | SCV000908631 | uncertain significance | Hereditary cancer-predisposing syndrome | 2019-01-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000774706 | SCV001172212 | uncertain significance | Hereditary cancer-predisposing syndrome | 2019-07-18 | criteria provided, single submitter | clinical testing | In silico models in agreement (benign);Insufficient evidence;Rarity in general population databases (dbsnp, esp, 1000 genomes) |